TAVI Proficiency Doesn't Spell Success for M-TEER at Large US Sites
Just one in nine US centers had similar short-term outcomes with TAVI and M-TEER, say researchers.
Stay updated with breaking news from Charanjit Rihal. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Just one in nine US centers had similar short-term outcomes with TAVI and M-TEER, say researchers.
Would intervention beat watchful waiting for asymptomatic patients with severe aortic stenosis?
Some hospitals are requiring tests to gauge competency—how best to balance wisdom with the inevitable declines of age.
Access to genetic tests is limited right now, but experts call for industry to develop new technologies that can be easily used.
April 19, 2021 Selecting a post-PCI antiplatelet regimen based on platelet function or genetic testing seems to improve both efficacy and safety, according to a new meta-analysis. Its authors say the results support the next frontier of personalized medicine despite the lack of randomized trial evidence. Prior studies, like last year’s TAILOR-PCI, have failed to establish the superiority of a guided antiplatelet strategy over standard therapy, but proponents say no trial so far has been accurately powered to do so. This 20,000-patient meta-analysis, which combined the TAILOR-PCI, POPular Ge...